Literature DB >> 30924644

Combined Computational-Experimental Approach to Explore the Molecular Mechanism of SaCas9 with a Broadened DNA Targeting Range.

Binquan Luan1, Guangxue Xu2, Mei Feng3, Le Cong4, Ruhong Zhou1,3.   

Abstract

Despite accelerating development of CRISPR technology, there remains high demand for further interrogation of its fundamental biology. This is particularly fascinating as new improved CRISPR tools were artificially engineered to harbor beneficial features but often lack mechanistic explanation. SaCas9, a minimal Cas9 ideal for in vivo applications, suffers from long protospacer adjacent motif (PAM), which prompted effort on mutant KKH SaCas9 with relaxed PAM requirement. Leveraging structure-based molecular dynamics simulation, free-energy perturbation, and targeted experimentation, we developed a workflow for probing SaCas9 and a series of its variants, revealing intriguing dynamics of PAM recognition and the molecular mechanism of KKH mutations. Furthermore, we deployed this approach to design and validate new mutant SaCas9, SaCas9-NR and SaCas9-RL, with enhanced targeting range distinctive from the KKH mutant and improved activity in mammalian cells. Overall, our approach provides a dynamic understanding of SaCas9 PAM recognition and a new gateway to enlighten rationally designed Cas9 variants harboring novel properties.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30924644     DOI: 10.1021/jacs.8b13144

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  12 in total

1.  In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers.

Authors:  David R Bell; Jeffrey K Weber; Wang Yin; Tien Huynh; Wei Duan; Ruhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-31       Impact factor: 11.205

2.  In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease.

Authors:  Tien Huynh; Haoran Wang; Binquan Luan
Journal:  J Phys Chem Lett       Date:  2020-05-21       Impact factor: 6.475

Review 3.  CRISPR technologies and the search for the PAM-free nuclease.

Authors:  Daphne Collias; Chase L Beisel
Journal:  Nat Commun       Date:  2021-01-22       Impact factor: 14.919

4.  Crystal-structures-guided design of fragment-based drugs for inhibiting the main protease of SARS-CoV-2.

Authors:  Binquan Luan; Tien Huynh
Journal:  Proteins       Date:  2021-10-21

5.  Machine learning-coupled combinatorial mutagenesis enables resource-efficient engineering of CRISPR-Cas9 genome editor activities.

Authors:  Dawn G L Thean; Hoi Yee Chu; John H C Fong; Becky K C Chan; Peng Zhou; Cynthia C S Kwok; Yee Man Chan; Silvia Y L Mak; Gigi C G Choi; Joshua W K Ho; Zongli Zheng; Alan S L Wong
Journal:  Nat Commun       Date:  2022-04-25       Impact factor: 17.694

6.  In Silico Antibody Mutagenesis for Optimizing Its Binding to Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Binquan Luan; Tien Huynh
Journal:  J Phys Chem Lett       Date:  2020-11-04       Impact factor: 6.475

Review 7.  Delivery Approaches for Therapeutic Genome Editing and Challenges.

Authors:  Ilayda Ates; Tanner Rathbone; Callie Stuart; P Hudson Bridges; Renee N Cottle
Journal:  Genes (Basel)       Date:  2020-09-23       Impact factor: 4.096

Review 8.  CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.

Authors:  Fathema Uddin; Charles M Rudin; Triparna Sen
Journal:  Front Oncol       Date:  2020-08-07       Impact factor: 6.244

9.  High-fidelity KKH variant of Staphylococcus aureus Cas9 nucleases with improved base mismatch discrimination.

Authors:  Chaya T L Yuen; Dawn G L Thean; Becky K C Chan; Peng Zhou; Cynthia C S Kwok; Hoi Yee Chu; Maggie S H Cheung; Bei Wang; Yee Man Chan; Silvia Y L Mak; Anskar Y Leung; Gigi C G Choi; Zongli Zheng; Alan S L Wong
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 16.971

10.  Insights into SARS-CoV-2's Mutations for Evading Human Antibodies: Sacrifice and Survival.

Authors:  Binquan Luan; Tien Huynh
Journal:  J Med Chem       Date:  2021-04-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.